Gefitinib G039-5G

产品介绍

Gefitinib is commonly used as an anti-lung and anti-breast cancer agent. Gefitinib acts as an inhibitor of mutated or overactive epidermal growth factor receptor (EGFR) by binding to the ATP binding site. Because epidermal growth factors are responsible for controlling cell growth and proliferation, a mutated form would likely facilitate cancer growth and development. Gefitinib is sparingly soluble in aqueous solution (0.027 mg/mL).

This product is considered a dangerous good. Quantities above 1 g may be subject to additional shipping fees. Please contact us for specific questions.